Vigisom Melatonin 2mg 30 Tablets OTC
General Information
Vigisom (melatonin) Prolonged Release Tablets 2mg is a Pharmacy Medicine for the short treatment of insomnia characterised by poor quality of sleep in patients aged 55 or over.
Warnings
Always read the label and use as directed. If symptoms persist see your healthcare professional.
PRECAUTIONS: renal insufficiency, hepatic impairment, may cause drowsiness, use in the elderly, not recommended in patients with autoimmune diseases, galactose intolerance, LAPP lactase deficiency, glucose-galactose malabsorption, children <18 years, pregnancy (Category B3) and lactation. Patients should avoid engaging in hazardous activities (eg driving/operating machinery) after taking Vigisom.
COMMON SIDE EFFECTS: Headache, nasopharyngitis, back pain and arthralgia.
Common Uses
For the short treatment of insomnia characterised by poor quality of sleep in patients aged 55 or over.
Ingredients
Vigisom (melatonin) Prolonged Release Tablets 2mg. The active ingredient in VIGISOM prolonged release tablets is a melatonin NOT of plant or animal origin.
Directions
DOSAGE AND ADMINISTRATION: Swallow tablets whole. One tablet daily after food 1-2 hours before bedtime. Treat for up to thirteen weeks.